Literature DB >> 20582505

[Not Available].

Klaus Fellermann.   

Abstract

Year:  2010        PMID： 20582505     DOI： 10.1007/s00063-010-1076-9

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN： 0723-5003


× No keyword cloud information.
  26 in total

1.  Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial.

Authors:  J Galperín; M V Elizari; P A Chiale; R T Molina; R Ledesma; A O Scapín; M Vázquez Blanco
Journal:  J Cardiovasc Pharmacol Ther       Date:  2001-10       Impact factor: 2.457

2.  A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

Authors:  Jean-Yves Le Heuzey; Gaetano M De Ferrari; David Radzik; Massimo Santini; Junren Zhu; Jean-Marc Davy
Journal:  J Cardiovasc Electrophysiol       Date:  2010-04-06

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy.

Authors:  Kenji Goto; Alexandra J Lansky; Martin Fahy; Ecatarina Cristea; Frederick Feit; E Magnus Ohman; Harvey D White; Karen P Alexander; Michel E Bertrand; Walter Desmet; Martial Hamon; Roxana Mehran; Gregg W Stone
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

5.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

6.  Amiodarone versus sotalol for atrial fibrillation.

Authors:  Bramah N Singh; Steven N Singh; Domenic J Reda; X Charlene Tang; Becky Lopez; Crystal L Harris; Ross D Fletcher; Satish C Sharma; J Edwin Atwood; Alan K Jacobson; H Daniel Lewis; Dennis W Raisch; Michael D Ezekowitz
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

7.  A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation.

Authors:  Kevin S Channer; Andrew Birchall; Richard P Steeds; Stephen J Walters; Wilf W Yeo; John N West; Rangasamy Muthusamy; Walter E Rhoden; Basil T Saeed; Phillip Batin; W Paul Brooksby; Ian Wilson; Simon Grant
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

8.  Prognostic value of a coronary artery jeopardy score.

Authors:  R M Califf; H R Phillips; M C Hindman; D B Mark; K L Lee; V S Behar; R A Johnson; D B Pryor; R A Rosati; G S Wagner
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

9.  Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab).

Authors:  D W Dunstan; E L M Barr; G N Healy; J Salmon; J E Shaw; B Balkau; D J Magliano; A J Cameron; P Z Zimmet; N Owen
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

Review 10.  Physical inactivity: a cardiovascular risk factor.

Authors:  D S Prasad; B C Das
Journal:  Indian J Med Sci       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.